13-23333578-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_014363.6(SACS):c.10298C>T(p.Thr3433Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,613,522 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T3433R) has been classified as Uncertain significance.
Frequency
Consequence
NM_014363.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charlevoix-Saguenay spastic ataxiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SACS | NM_014363.6 | MANE Select | c.10298C>T | p.Thr3433Ile | missense | Exon 10 of 10 | NP_055178.3 | ||
| SACS | NM_001437336.1 | c.10325C>T | p.Thr3442Ile | missense | Exon 11 of 11 | NP_001424265.1 | |||
| SACS | NM_001278055.2 | c.9857C>T | p.Thr3286Ile | missense | Exon 8 of 8 | NP_001264984.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SACS | ENST00000382292.9 | TSL:5 MANE Select | c.10298C>T | p.Thr3433Ile | missense | Exon 10 of 10 | ENSP00000371729.3 | ||
| SACS | ENST00000455470.6 | TSL:1 | c.2432-4094C>T | intron | N/A | ENSP00000406565.2 | |||
| SACS | ENST00000682944.1 | c.10325C>T | p.Thr3442Ile | missense | Exon 11 of 11 | ENSP00000507173.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152074Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000275 AC: 69AN: 250782 AF XY: 0.000199 show subpopulations
GnomAD4 exome AF: 0.000142 AC: 207AN: 1461448Hom.: 2 Cov.: 57 AF XY: 0.000131 AC XY: 95AN XY: 727036 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000164 AC: 25AN: 152074Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Charlevoix-Saguenay spastic ataxia Uncertain:1Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
Spastic paraplegia Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at